Clinical Trial Update: Trastuzumab, Bevacizumab with Paclitaxel for HER2-positive Gastric Cancer in a Second-line Therapy [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update indicating ongoing recruitment for a Phase 1/2 study of trastuzumab, bevacizumab, and paclitaxel in HER2-positive advanced gastric cancer …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• PACLITAXEL (PACLITAXEL)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Kangbuk Samsung Hospital | Conditions: HER2-positive Advanced Gastric Cancer | Phase 1, Phase 2 | Status: RECRUITING